Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 174

Modsy draws up $37m series C

The 3D-imaging interior design service took its overall funding to more than $70m in a round that featured Comcast Ventures and Advance Venture Partners.

May 23, 2019

Corporates buy into Biofourmis in $35m round

MassMutual Ventures co-led the healthcare data platform developer's series B round, which also featured Aviva Ventures and Jianke.

May 23, 2019

Sun Basket orders $30m in fresh funding

Unilever Ventures participated in a series E round that increased the healthy meal delivery service's overall funding to $125m.

May 22, 2019

Robin lands on $20m for series B

Allegion's corporate venturing arm has taken part in a $20m round for the office management software provider, whose early backers include Autodesk and Konica Minolta.

May 22, 2019

Snapsheet lays claim to $29m

The digital insurance software provider Snapsheet has closed a $29m series E featuring Nationwide, Sedgwick, State Automobile Mutual Insurance Liberty Mutual, Fidelity and USAA.

May 21, 2019

Prowler.io pounces on $24m

CIC has returned to supply AI forecasting platform Prowler.io with series B capital and help take the company's overall funding to $39m.

May 21, 2019

Prowler.io pounces on $24m

Pearson, Tencent and Mandatum Life helped supply the AI forecasting platform developer with series B capital that took its total funding to $39m.

May 21, 2019

Storm attracts more series A funding

M Ventures, Pfizer Ventures and Taiho Ventures all returned to help boost cancer drug developer Storm Therapeutics' series A round to $38.2m.

May 20, 2019

Storm's series A continues to resound with investors

Cambridge's cancer drug spinout Storm Therapeutics convinced its existing investors to join new participant Seroba Life Sciences for a second extension that brought its series A total to $38.2m.

May 20, 2019

DNA Script reaches series B chapter

Illumina Ventures and M Ventures made follow-on investments in synthetic DNA platform developer DNA Script as part of its $38.5m series B round.

May 20, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here